Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
11.67
-0.13 (-1.10%)
At close: Jul 24, 2026, 4:00 PM EDT
11.59
-0.08 (-0.69%)
Pre-market: Jul 27, 2026, 7:53 AM EDT

Core Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
524.73526.52523.85509.79489.74470.25
Revenue Growth
1.34%0.51%2.76%4.09%4.14%-3.49%
Cost of Revenue
420.19417.59420.52399.96393.66367.9
Gross Profit
104.54108.93103.33109.8396.08102.36
Selling, General & Admin
46.545.4339.7740.2638.1244.17
Depreciation & Amortization Expenses
414.6514.9515.7817.1618.52
Other Operating Expenses
-10.59-7.61-9.95---5.6
Total Operating Expenses
39.9152.4744.7756.0455.2857.09
Operating Income
53.9456.4758.5654.6441.5245.26
Interest Expense
-10.86-10.57-12.37-13.43-11.57-9.15
Other Non-Operating Income (Expense)
----0.85-0.72-
Total Non-Operating Income (Expense)
-10.86-10.57-12.37-14.28-12.29-9.15
Pretax Income
43.0845.946.1941.2129.9536.11
Provision for Income Taxes
13.5115.5114.034.1910.315.89
Net Income
29.5730.3932.1537.0319.6620.22
Minority Interest in Earnings
0.540.720.750.350.210.49
Net Income to Common
29.0329.6731.436.6819.4519.73
Net Income Growth
3.60%-5.51%-14.38%88.53%-1.39%-
Shares Outstanding (Basic)
464647474646
Shares Outstanding (Diluted)
474748484747
Shares Change
31.48%-1.38%0.34%1.52%0.26%4.98%
EPS (Basic)
0.630.640.670.790.420.43
EPS (Diluted)
0.610.630.660.770.420.42
EPS Growth
3.39%-4.54%-14.29%83.33%0%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
18.4422.4443.3614.2114.7423.04
Free Cash Flow Growth
-58.81%-48.24%205.14%-3.60%-36.02%-49.90%
Free Cash Flow Per Share
0.390.480.910.300.310.49
Dividends Per Share
0.0400.0400.0400.0400.0400.040
Dividend Growth
0%0%0%0%0%-85.71%
Gross Margin
19.92%20.69%19.72%21.54%19.62%21.77%
Operating Margin
10.28%10.72%11.18%10.72%8.48%9.63%
Profit Margin
5.64%5.77%6.14%7.26%4.01%4.30%
FCF Margin
3.51%4.26%8.28%2.79%3.01%4.90%
EBITDA
68.6371.1273.5170.4258.6963.78
EBITDA Margin
13.08%13.51%14.03%13.81%11.98%13.56%
EBIT
53.9456.4758.5654.6441.5245.26
EBIT Margin
10.28%10.72%11.18%10.72%8.48%9.63%
Effective Tax Rate
31.36%33.78%30.39%10.16%34.37%44.01%
SEC Filings: 10-K · 10-Q